181 related articles for article (PubMed ID: 6363908)
1. Report of ICPEMC Task Group 5 on the differentiation between genotoxic and non-genotoxic carcinogens.
Mutat Res; 1984 Jan; 133(1):1-49. PubMed ID: 6363908
[No Abstract] [Full Text] [Related]
2. The effect of dieldrin and phenobarbital on preneoplastic hepatic lesion growth in male F344 rat and B6C3F1 mouse.
Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
Prog Clin Biol Res; 1995; 391():409-23. PubMed ID: 8532733
[No Abstract] [Full Text] [Related]
3. Influence of liver tumor promoters and structurally related chemicals on survival of normal adult rat hepatocytes in primary culture.
Miyazaki M; Bai L; Sato J
J Cancer Res Clin Oncol; 1990; 116(3):259-63. PubMed ID: 2370251
[TBL] [Abstract][Full Text] [Related]
4. Liver tumour promotion by phenobarbital: comparison of rat and human studies.
McLean AE; Driver HE; Sutherland IA
Prog Clin Biol Res; 1992; 374():251-9. PubMed ID: 1320274
[No Abstract] [Full Text] [Related]
5. The species specificity of dieldrin- or phenobarbital- induced hepatocarcinogenesis: case studies with implications for human health risk assessment.
Stevenson DE; Walborg EF; Klaunig JE
Prog Clin Biol Res; 1995; 391():337-45. PubMed ID: 8532726
[No Abstract] [Full Text] [Related]
6. Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis.
Oliver JD; Roberts RA
Pharmacol Toxicol; 2002 Jul; 91(1):1-7. PubMed ID: 12193254
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of test methods for examining promoters of hepatocarcinogenesis--promoting effects of phenobarbital, butylated hydroxytoluene and barbital].
Furukawa F; Toyoda K; Kokubo T; Takahashi M; Hayashi Y
Eisei Shikenjo Hokoku; 1984; (102):71-6. PubMed ID: 6532509
[No Abstract] [Full Text] [Related]
8. Comparison of carcinogenic and in vivo genotoxic potency estimates.
Sanner T; Dybing E
Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
[TBL] [Abstract][Full Text] [Related]
9. Strain and species effects on the inhibition of hepatocyte intercellular communication by liver tumor promoters.
Klaunig JE; Ruch RJ
Cancer Lett; 1987 Aug; 36(2):161-8. PubMed ID: 3621148
[TBL] [Abstract][Full Text] [Related]
10. Review: putative mutagens and carcinogens in foods. III. Butylated hydroxytoluene (BHT).
Malkinson AM
Environ Mutagen; 1983; 5(3):353-62. PubMed ID: 6343068
[TBL] [Abstract][Full Text] [Related]
11. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
[TBL] [Abstract][Full Text] [Related]
12. The unique role of rodents in the detection of possible human carcinogens and mutagens.
Ashby J
Mutat Res; 1983 Jun; 115(2):177-213. PubMed ID: 6343849
[TBL] [Abstract][Full Text] [Related]
13. Assembling a battery of assays to predict carcinogenicity: a case study.
Rosenkranz HS; Pet-Edwards J; Chankong V; Haimes YY
Mutat Res; 1984 Sep; 141(1):65-8. PubMed ID: 6482896
[No Abstract] [Full Text] [Related]
14. Phenobarbital mouse liver tumors: implications of hepatic tumor promotion for cancer risk assessment.
McClain RM
Prog Clin Biol Res; 1995; 391():325-36. PubMed ID: 8532725
[No Abstract] [Full Text] [Related]
15. The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, -BHC and -BHC.
Thorpe E; Walker AI
Food Cosmet Toxicol; 1973 Jun; 11(3):433-42. PubMed ID: 4125578
[No Abstract] [Full Text] [Related]
16. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
17. Cellular effects of chemical carcinogens.
Williams GM
Dev Toxicol Environ Sci; 1986; 12():371-82. PubMed ID: 3549238
[No Abstract] [Full Text] [Related]
18. Risk assessment for carcinogenesis promoting agents: need for a weight of all the evidence approach.
Clayson DB
Prog Clin Biol Res; 1995; 391():359-67. PubMed ID: 8532728
[No Abstract] [Full Text] [Related]
19. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
[TBL] [Abstract][Full Text] [Related]
20. Medical and toxicological research on dieldrin and related compounds.
Jansen JD
Environ Qual Saf; 1976; 5():208-14. PubMed ID: 829668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
